Home › Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia clinical trials recruiting in the U.S.
134 studies for Acute Lymphoblastic Leukemia are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX28 studies
- New York City, NY24 studies
- Baldwin Park, CA21 studies
- Seattle, WA21 studies
- Atlanta, GA19 studies
- Chicago, IL19 studies
- Memphis, TN16 studies
- Philadelphia, PA16 studies
- Washington, DC16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
- Mountain View, CA13 studies
- Cincinnati, OH12 studies
- Minneapolis, MN12 studies
- Columbus, OH11 studies
- Tampa, FL10 studies
- Salt Lake City, UT10 studies
- Baltimore, MD9 studies
- Portland, OR9 studies
- Miami, FL8 studies
- Aurora, CO8 studies
- San Antonio, TX8 studies
- Nashville, TN8 studies
- Charlotte, NC8 studies
- Edison, NJ8 studies
- Cleveland, OH7 studies
- Birmingham, AL7 studies
- Denver, CO7 studies
- Pittsburgh, PA6 studies
- Oklahoma City, OK6 studies
- Milwaukee, WI6 studies
- Detroit, MI6 studies
- Phoenix, AZ6 studies
- San Diego, CA6 studies
- St. Louis, MO6 studies
- Queens, NY6 studies
- San Francisco, CA5 studies
- Clifton, NJ5 studies
- The Bronx, NY5 studies
By state
- Alabama7 studies
- Arizona6 studies
- Arkansas5 studies
- California40 studies
- Colorado12 studies
- Connecticut3 studies
- District of Columbia10 studies
- Florida19 studies
- Georgia20 studies
- Hawaii3 studies
- Illinois20 studies
- Indiana6 studies
- Iowa5 studies
- Kansas5 studies
- Kentucky4 studies
- Louisiana6 studies
- Maine3 studies
- Maryland16 studies
- Massachusetts15 studies
- Michigan8 studies
- Minnesota14 studies
- Mississippi3 studies
- Missouri6 studies
- Nebraska4 studies
- Nevada3 studies
- New Jersey11 studies
- New Mexico3 studies
- New York32 studies
- North Carolina21 studies
- Ohio21 studies
- Oklahoma8 studies
- Oregon10 studies
- Pennsylvania21 studies
- Rhode Island3 studies
- South Carolina5 studies
- South Dakota3 studies
- Tennessee22 studies
- Texas30 studies
- Utah10 studies
- Virginia9 studies
- Washington22 studies
- West Virginia4 studies
- Wisconsin9 studies
Recently updated studies
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
RecruitingPhase 1
Up to age 75 · All sexes · Updated Oct 2, 2026 · NCT01853631A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Recruiting
Ages 1 to 25 · All sexes · Updated Oct 2, 2026 · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06904066Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT07572136Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 1, 2026 · NCT06131801CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
RecruitingPhase 2
Ages 3 to 65 · All sexes · Updated Sep 30, 2026 · NCT07328503CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RecruitingPhase 1/2
Ages 3 to 39 · All sexes · Updated Sep 30, 2026 · NCT05442515A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RecruitingPhase 1
Ages 12 to 78 · All sexes · Updated Sep 29, 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06144606Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06398457Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
RecruitingObservational study
4 Weeks – 18 Years · All sexes · Updated Sep 24, 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06819475A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RecruitingPhase 1/2
30 Days · All sexes · Updated Sep 16, 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RecruitingPhase 1
Ages 0 to 18 · All sexes · Updated Sep 16, 2026 · NCT06173518Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
RecruitingPhase 2
Ages 21 to 65 · All sexes · Updated Sep 11, 2026 · NCT05884333Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
RecruitingPhase 1/2
Ages 16 to 75 · All sexes · Updated Sep 10, 2026 · NCT03104491Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
RecruitingPhase 1
Ages 1 to 25 · All sexes · Updated Sep 1, 2026 · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07586618Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
RecruitingPhase 1/2Healthy volunteers welcome
Up to age 50 · All sexes · Updated Sep 1, 2026 · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
RecruitingPhase 1
Up to age 21 · All sexes · Updated Aug 31, 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
RecruitingPhase 1
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT07257419From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.